Fractional Flow Reserve versus angiography for multivessel evauation (FAME 3) trial. A comparison of fractional flow reserve guided percutaneous coronary intervention and coronary artery bypass graft surgery in patients with multivessel coronary artery disease.

Fractional Flow Reserve versus angiography for multivessel evauation (FAME 3) trial. A comparison of fractional flow reserve guided percutaneous coronary intervention and coronary artery bypass graft surgery in patients with multivessel coronary artery disease. - FFR guided PCI versus coronary bypass surgery.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON44384

Enrollment

155

Registered

2014-08-14

Start date

2014-06-01

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery disease coronary atherosclerosis narrowings in the coronary arteries.

Interventions

Coronary artery bypass surgery (CABG) versus percutaneous coronary intervention (PCI)

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with angina pectoris or evidence of myocardial ischemia, age >21 years, with three vessel coronary artery disease and able to provide written informed consent.

Exclusion criteria

Exclusion criteria: - cardiogenic shock - recenty myocaridal infarction - concommitant need foor valve surgery or carotic surgery - poor left ventricular injection fraction - other serious concommitant disease.

Design outcomes

Primary

Measure	Time frame
Death, myocardial infarction, any repeat revascularization, stroke	—

Secondary

Measure	Time frame
-Individual components of the primary endpoint. -Bleeding complications, stent thrombosis, arrhythmia, acute renal failure, length of hospital stay, cost	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)